Over 200 adverse events were reported with a single injection of resiniferatoxin in 19 patients with refractory cancer pain. At least one adverse event occurred in all patients. Resiniferatoxin was ...
The world's largest review on opioid medicines for cancer pain has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that non-opioid medicines, ...
RTX is a non-addictive pain therapy derived from a cactus-like plant. National Institute of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results